Kidney affected with CDK due to Ultr-processed Food(UPF)
CKD Risk from Ultra-Processed Foods

CKD Risk from Ultra-Processed Foods The risk of Chronic Kidney Disease (CKD) is evaluated concerning.

Sleep Disorders Linked to Increased Healthcare Utilization in Chronically Ill Children
Sleep Disorders Linked to Increased Healthcare Utilization in Chronically Ill Children

The propensity for heightened healthcare engagement in children with chronic medical ailments escalates significantly when.

Phone addiction associated with increased insomnia risks.
Phone Addiction linked with Insomnia: New Study Insights

In addition to confirming the well-established link between mobile phone addiction and sleeplessness, a recent.

Linking IBS and PD: Cohort Study Insights
PD Influence on Irritable Bowel Syndrome: Study Discoveries

Researchers investigate the connection between irritable bowel syndrome (IBS) and Parkinson’s disease (PD) in a.

Monkeypox Vaccine Antibody Response Declines Over Time
Monkeypox Vaccine Antibody Response Declines Over Time

New findings set to be unveiled at this year’s European Congress of Clinical Microbiology and.

Abzymes
Abzymes Unveiled: Understanding COVID-19’s Impact

A possible solution for some of the most puzzling riddles surrounding COVID-19 and extended COVID.

Cardiovascular Risk in Young Women
Link Between Mental Health and Cardiovascular Risk in Young Women

Younger females are commonly believed to possess a diminished susceptibility to cardiac ailments, yet recent.

Brain Tumor
Prolonged Use of Cyproterone Acetate Links to Brain Tumor

A study of over 250,000 women in France published today in The BMJ found that.

Urban environment's role in heart disease risk factors.
Risk Factors for Heart Disease: Google Street View Insights

Hundreds of features of the built environment, such as buildings, green spaces, pavements, and roadways,.

FDA Approves Sotatercept-csrk to Treat Pulmonary Arterial Hypertension
FDA Approves Sotatercept to Treat Patients with Pulmonary Arterial Hypertension

The FDA has approved Merck’s Sotatercept-csrk (Winrevair) for the treatment of patients with pulmonary arterial.